CRCardiovascular Reviews3083-48802981-8109Bio-Byword Scientific Publishing Pty. Ltd.10.26689/cr.v3i2.10938ArticleA Bibliometric and Knowledge-map Analysis of Gut Microbiota in Cardiovascular Diseases from 2006 to 2024https://artdesignp.com/journal/CR/3/2/10.26689/cr.v3i2.10938JingRong,BaiMin,LiuYan,SuHui,LiuHe,HouLiming2025322025-07-02Cardiovascular disease continues to be a leading cause of death and morbidity worldwide. The study employed bibliometric and knowledge-mapping analyses to explore research trends in cardiovascular disease, identifying emerging hotspots and offering new perspectives for scholars. The study conducted a comprehensive search within the WOSCC on December 28th, 2024, to retrieve articles and reviews that explore the association between gut microbiota and cardiovascular diseases. Citespace and VOSviewer were used to conduct the bibliometric and knowledge-map analysis. The analysis encompassed 1,680 studies published across 289 academic journals, authored by 9,865 researchers from 277 institutions spanning 103 countries/regions. The United States, China, Italy, and India emerged as the leading contributors, with the most cited institutions including the University of California system, INSERM, the Chinese Academy of Medical Sciences & Peking Union Medical College, and Southern Medical University (China). Among journals, Nutrients published the highest number of studies, while Nature, Gut, and the American Journal of Clinical Nutrition were the most frequently co-cited. The most prominent research focus centered on biochemistry and molecular biology, with four key cardiovascular conditions: heart failure, cardiometabolic disorders, infarction, and hypertension. GO and KEGG pathway analyses further revealed 30 critical biological processes and 21 signaling pathways linked to gut microbiota and cardiovascular disease. Additionally, PPI network analysis highlighted IFNG, IL10, TLR4, INS, TNF, IL6, IL1β, APOE, and AGT as potential core therapeutic targets for future research. Our analyses elucidated key research trends linking gut microbiota to cardiovascular diseases, highlighting metabolic modulation and prebiotic supplementation as promising therapeutic strategies.

Leopold J, 2018, The Emerging Role of Precision Medicine in Cardiovascular Disease. Circ Res, 122: 1302–1315.

Fang N, Fan Y, 2023, Ideal Cardiovascular Health Metrics and Risk of Cardiovascular Disease or Mortality: A Meta-Analysis. Int J Cardiol, 12: 279–283.

Witkowski M, Weeks T, 2020, Gut Microbiota and Cardiovascular Disease. Circ Res, 127: 553–570.

Yang J, Wang A, Shang L, et al., 2024, Prebiotics Improve Frailty Status in Community-Dwelling Older Individuals in a Double-Blind, Randomized, Controlled Trial. J Clin Invest, 134: e176507–e176515.

Rahman M, Harun-Or-Rashid, Mamun A, et al., 2022, The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Front Cell Infect Microbiol, 12: 1–22.

Chen X, Ren S, Ding Y, et al., 2023, Gut Microbiota and Microbiota-Derived Metabolites in Cardiovascular Diseases. Chin Med J (Engl), 136: 2269–2284.

Verhaar B, Nieuwdorp M, Muller M, 2020, Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients, 12: 2982–3004.

Wang Z, 2018, Gut Microbiota Derived Metabolites in Cardiovascular Health and Disease. Protein Cell, 9: 416–431.

Mao Y, Chen N, Fu Q, et al., 2023, A 2-Decade Bibliometric Analysis of Epigenetics of Cardiovascular Disease: From Past to Present. Clin Epigenetics, 15: 184–192.

Liang Y, Bai M, Tang M, et al., 2024, A Knowledge Map of the Relationship Between Diabetes and Stroke: A Bibliometric Analysis Study. Cerebrovasc Dis, 53: 270–287.

Miao L, Zhang Z, Wang S, et al., 2022, A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021. Front Immunol, 13: 840956–840963.

Song L, Ma D, Fan Y, et al., 2022, A Bibliometric and Knowledge-Map Analysis of Macrophage Polarization in Atherosclerosis From 2001 to 2021. Front Immunol, 13: 910444–910461.

Zhang J, Miao L, 2022, A Bibliometric and Scientific Knowledge-Map Study of the Chimeric Antigen Receptor (CAR) Natural Killer (NK) Cell-Related Research From 2010 to 2022. Front Immunol, 13: 969196–969201.

Guan B, Hao H, Yang Z, et al., 2022, Bile Acid Coordinates Microbiota Homeostasis and Systemic Immunometabolism in Cardiometabolic Diseases. Acta Pharm Sin B, 12: 2129–2149.

Kaye D, Jama H, 2020, Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease. Circulation, 141: 1393–1403.

Wang Z, Bennett B, Koeth R, et al., 2011, Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease. Nature, 472: 57–63.

Zhang Y, Ke B, Du J, 2021, TMAO: How Gut Microbiota Contributes to Heart Failure. Transl Res, 228: 109–125.

Tang W, Levison B, Koeth R, et al., 2013, Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk. N Engl J Med, 368: 1575–1584.

Seldin M, Qi H, Zhu W, et al., 2016, Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-jB. J Am Heart Assoc, 5: e002767–e002771.

Nemet I, Gupta N, Zhu L, et al., 2020, A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell, 180: 862–877.

Gosho S, Nagashima K, Takahashi S, 2017, Statistical Methods in the Journal — An Update. N Engl J Med, 376: 1086–1087.

Ninkov A, Maggio L, 2022, Bibliometrics: Methods for Studying Academic Publishing. Perspect Med Educ, 11: 173–176.